Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 22, 2023 (3 years ago)

B-Complex

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3

Affected NDC 72682-2230-03

Compare with the code on your package — it is the most precise check available.

Drug: Pyridoxine

Recalling firm
AnazaoHealth Corporation
NDC code
72682-2230-3
Origin
NV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0203-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Pyridoxine recalls

See all
Class II · Moderate risk

LX Bioboost Plus

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0477-2025

Other recalls by AnazaoHealth Corporation

All 2023 recalls
Class II · Moderate risk

Compounded Plaquex

Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

Terminated Unapproved drug AnazaoHealth Corporation D0384-2015